This study examined whether Toll-like receptors 2 (TLR2) contribute to rapid kindling epileptogenesis. A TLR2 agonist, lipoteichoic acid (LTA), LTA antibody (LTA-A), or normal saline (control) was administered daily over 3 consecutive days, unilaterally into ventral hippocampus of adult male Wistar rats. Thirty minutes after the last injection, the animals were subjected to a rapid kindling procedure. The ictogenesis was gauged by comparing afterdischarge threshold (ADT) and afterdischarge duration (ADD) before the treatments, after the treatments prior to kindling, and 24 h after kindling. Kindling progression and retention were analyzed using video recording. The results showed that before kindling, LTA produced an ADT reduction. Neither LTA nor LTA-A affected baseline ADD. On kindling progression, LTA accelerated occurrence of generalized seizures, whereas LTA-A delayed this effect. Treatment with LTA-A reduced the number of secondary generalized complex partial seizures. Twenty-four hours after kindling, the rats of both the saline and LTA groups showed increased hippocampal excitability as compared with prekindling parameters. Administration of LTA-A prevented kindling-induced increase of hippocampal excitability. Immunostaining revealed that LTA-A attenuated the inflammatory response produced by seizures. These findings suggest that the activation of TLR2 in the hippocampus may facilitate limbic epileptogenesis.
Clinical and experimental evidence implicates brain inflammation in mechanisms of epilepsy. 1 Studies of refractory epilepsy in humans show increased brain expression of proinflammatory cytokines (interleukin [IL]-1b, IL-6), stress signals, and increased circulating levels of inflammatory mediators. 2 Genetic and pharmacological studies suggest that the increased neuroinflammatory signaling induced by the activation of Toll-like receptors (TLRs) contributes to epilepsy. 3 TLRs are important components of innate immunity that recognize pathogens and molecules related to cell damage under stress conditions including epilepsy. 4 Ten members in the TLR family in humans and 12 members in rodents have been discovered. 5 TLRs recognize pathogen-associated molecular pattern of microbial origin. 5 TLRs 1, 2, 4, 5, and 6 bind to components of microbial cell walls, such as lipopolysaccharide (the endotoxin of Gramnegative bacteria), lipoproteins from the cell membrane, flagellin, and lipoteichoic acid (LTA). 6 LTA is an amphiphilic, negatively charged glycolipid anchored in the membrane of Gram-positive bacteria, and plays an important role in related infections and postinfectious sequelae. 7 Previous studies have shown that the expression of TLR2 is increased following kainic acid-induced seizures, and studies of TLR2-knockout mice reveal that TLR2 signaling promotes glia activation and contributes to neuronal death following kainic acid exposure in vitro. 8 Moreover, in the absence of pathogens that produce infection, as it occurs in the aseptic inflammation process, TLR inflammatory response is mediated by endogenous damage-associated molecular pattern (DAMP) molecules including high-mobility group box 1 (HMGB1), S100 calcium-binding protein B, and heat shock proteins (HSPs). In the central nervous system, HMGB1 is secreted by injured and necrotic cells, acting as a proinflammatory molecule binding its respective receptors (TLR2 and TLR4) expressed by glia. 5 Although TLR3 and TLR4 have been extensively examined in epilepsy, 9 the role of TLR2 signaling in the pathophysiology of the epileptic process has not been fully explored. We investigated the modulatory effects of a TLR2 agonist (LTA), mimicking a Gram-positive infection, and its antibody (LTA-A) on seizures in an animal model of limbic epilepsy, hippocampal rapid kindling.
Methods

Animals
Fifty-day-old male Wistar rats were used at the onset of experiments and maintained under standard vivarium conditions (temperature = 20-26°C, humidity = 30-70%, 12-h light-dark cycle, food and water ad libitum). All experiments adhered to National Institutes of Health standards, and guidelines were approved by the UCLA Animal Research Committee.
Surgery and afterdischarge properties
Under isoflurane anesthesia, rats were stereotaxically implanted with a cannula guide electrode (internal diameter = 0.39 mm; Plastics One, Roanoke, VA, U.S.A.) on the CA1 area of left ventral hippocampus (4.8 mm posterior and 5.3 mm lateral to bregma, 6.5 mm ventral). 10 A tripolar electrode for electroencephalographic recording (Plastics One) was placed 3 mm anterior to bregma with the ground connected to a screw on the nasal bone. The implantation site was identified by histology using Nissl staining.
Seven days after surgery, the animals were connected to a DS8000 electrical stimulator via DSI100 stimulus isolators (World Precision Instruments, Sarasota, FL, U.S.A.) and to the MP100/EEG100B acquisition system (BIOPAC, Goleta, CA, U.S.A.). The afterdischarge threshold (ADT), defined as a response of at least 2 s long at the end of the stimulation (Fig. 1A) , was detected by the application of trains of electrical stimulations (series of 10-s train duration, 20 Hz, 1-ms pulse duration, square-wave monophasic stimuli, starting 0.1 mA, at 0.1-mA increments, applied every 10 min). The afterdischarge duration (ADD) was also recorded, and measured off-line.
Drugs and treatments
Thirty minutes after the afterdischarge evaluation, the animals were randomly assigned to one of three treatment groups: normal saline (vehicle, 1 lL, n = 9), LTA (Sigma, St. Louis, MO; 50 lg in 1 lL of saline vehicle, n = 9), or LTA-A (Thermo Fisher Scientific, Waltham, MA, U.S.A.; 0.1 lg in 1 lL of saline vehicle, n = 9). Concentrations were chosen considering previous in vitro studies showing the neuroinflammatory activation of astrocytes by LTA 7 and the activation of sensitized monocytes by LTA-A. 11 We used concentrations approximately 10-fold lower than those reported as systemically proinflammatory to ensure brainspecific effects. The drugs were administered at a rate of 0.2 lL/min, using a 2-lL Hamilton microsyringe mounted onto microinfusion pump model sp310i (WPI, Sarasota, FL). The animals received three injections at 24-h intervals. Thirty minutes after the last injection, ADT and ADD values were detected for the second time to assess the effect of the treatments before performing rapid kindling.
Rapid kindling
Ten minutes after ADT detection, the animals received 60 trains delivered every 5 min, using the same parameters previously described, starting 50 lA above the ADT. The rats were continuously video-recorded during the entire procedure. Behavioral seizure responses to each stimulation and the number of stimulations required to reach each behavioral phase were quantified blindly off-line using the Racine scale. 12 For statistical analyses, when the rats skipped one of the consecutive seizure stages, the current value necessary to reach the subsequent stage was designated to the omitted phase (i.e., from stage 2 to stage 4 avoiding stage 3; the same result for stages 3 and 4 was assigned); when the animals did not display any of the fivestage score, 60 was assigned. The ADT and ADD were gauged once more 24 h after kindling.
Tumor necrosis factor-alpha immunohistochemistry
The expression of tumor necrosis factor-alpha (TNFa) has been shown to be upregulated by seizures. 13 We analyzed TNFa expression upon LTA-A administration and kindling-induced seizures in a separate group of rats. Thirty minutes after the last ADT/ADD detection, rats were anesthetized with pentobarbital (100 mg/kg intraperitoneally) and perfused with saline followed by 4% phosphate-buffered paraformaldehyde. Brains were postfixed for 2 h and cryoprotected in 30% sucrose. Immunofluorescence was performed in 40-lm-thick coronal sections of the hippocampus (1-2 mm anterior to implantation site), cut on a Leica sliding microtome, using primary goat polyclonal antibody against TNFa (1:200, AF-510-NA; R&D Systems, Minneapolis, MN) and donkey antigoat secondary antibody, Alexa Fluor 488 conjugate (1:500; Thermo Fisher Scientific). Sections were examined using a Leica microscope equipped with a Micropublisher 5 digital camera (QImaging, Barnaby, BC, Canada). Counting of TNFa-positive cells was performed bilaterally in the pyramidal layer of the subiculum-CA3 region of the dorsal hippocampus. The average of the number of injured cells was obtained from six randomly selected sections per animal.
Statistical analysis
Data were analyzed using the Prism 6.0 software (GraphPad Software, San Diego, CA, U.S.A.). Each experimental group passed the D'Agostino-Pearson normality test. Statistical analysis was carried out using one-way analysis of variance, followed by Tukey post hoc test. Data are presented as mean AE standard deviation of mean. A confidence level of 95% was accepted as significant.
Results
Effect of LTA and LTA-A on ADT/ADD on baseline hippocampal excitability
Thirty minutes after the completion of the 3-day treatment (before kindling procedure), the animals of the LTA group showed decreased ADT as compared with the baseline values. The LTA-A had no effects on baseline excitability. None of the administered treatments affected ADD (Fig. 1B) .
Kindling progression
Intrahippocampal administration of LTA reduced the number of stimulations required to reach the first stage 4-5 seizure. Conversely, treatment with LTA-A both delayed the onset and reduced the number of secondary generalized complex partial seizures. Furthermore, the antibody reduced the number of stage 2 and 3 seizures (Fig. 1C,D) .
Kindling retention
Twenty-four hours after kindling, the rats of both the saline and LTA groups showed increased hippocampal excitability as compared with prekindling parameters. There were no differences between the animals of the saline and LTA groups in terms of both ADT decrease and ADD increase induced by kindling. At the same time, LTA-A administration prevented kindling-induced increase of hippocampal excitability, judging by both ADT and ADD ( Fig. 2A) .
TNFa immunohistochemistry
The number of TNFa-positive cells was significantly higher in the hippocampus of kindled animals as compared with the naive rats. Intracerebral administration of LTA-A attenuated the inflammatory response produced by kindling (Fig. 2B-E) .
Discussion
The major findings of these studies are: (1) LTA reduced the number of stimulations required to reach generalized seizures, but had no significant effects on the afterdischarge parameters; and (2) LTA-A protected against the development of seizures and reduced the neuroinflammatory response induced by kindling. These findings suggest that TLR2 may be involved in regulating limbic epileptogenesis, even in the absence of Gram-positive infection. Thus, the activation of TLR2 in the hippocampus predisposed the animals to kindling, by increasing hippocampal excitability. At the same time, immunological blockade of TLR2 through introducing LTA-A reduced both seizure frequency and seizure severity. On the one hand, although LTA increased hippocampal excitability, it had no effects on kindling retention. On the other hand, there was a strong consistency between the kindling progression and kindling retention results, suggesting a protective effect of LTA-A against kindling-induced seizures. The most plausible explanation for the observed effects is that LTA-A administration could have blocked the activity of intracellular DAMPs, HMGB1 (located in the nucleus), or the HSPs and S100 calciumbinding proteins (found in the cytosol). It has been demonstrated by several studies that those DAMPs are synthesized and released by astrocytes and microglia during seizures, 14 and their signaling can be manipulated to prevent an exaggerated and detrimental inflammatory response. Admittedly, these suggestions should be further corroborated. TLR2 and TNFa are closely related proteins expressed after an insult, such as seizures.
3 TLR2 is a cell surface receptor that binds components of the Gram-positive bacterial cell walls and it is a marker of microglial activation during neuroinflammation, 8, 9 whereas TNFa is a proinflammatory cytokine that is quickly released following inflammatory stimuli. 15 Our results showed that intracerebral application of LTA-A reduced TNFa expression in the hippocampus of kindled animals, which confirms the close relationship between expression of this cytokine and activation of TLR2 signaling during the neuroinflammatory process induced by seizures. These results confirm earlier observations, such as increased TNFa expression after pilocarpine status epilepticus. 16 It has been shown that after pilocarpine-induced seizures, TLR2 and TNFa transcripts were expressed mainly in microglia/macrophages across the cerebral cortex, hippocampal formation, amygdala, thalamus, and hypothalamus following convulsive activity. 16 We observed that unilateral administration with LTA-A reduced the number of hippocampal TNFa-positive cells in both hemispheres. The involvement of the contralateral hippocampus was secondary, and would not occur if epileptic activity in the primary focus is suppressed. Because in our studies, LTA-A was administered prior to the induction of kindling, it is reasonable to assume that the alleviation of epileptic activity at the site of primary stimulation also prevented the spread of this activity to the contralateral side. This suggestion was corroborated by the finding that pretreatment with LTA-A reduced TNFa expression both ipsiand contralaterally to the stimulation. Other studies have shown that unilateral modulation of epileptic activity inhibits kindling seizures. 17 In conclusion, our results suggest the involvement of TLR2 in kindling epileptogenesis and kindling-induced increase of seizure susceptibility. We also demonstrated that the exogenous inhibition of TLR2 signaling reduced hippocampal neuroinflammation associated with seizures.
